Skip to Content

'
Monica E. Loghin, M. D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Residency Program Director, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Bio Statement

Dr. Loghin is an Assistant Professor of Neuro-Oncology at M. D. Anderson Cancer Center.  She completed her neurology residency training at University of Texas Health Science Center and thereafter she was accepted and completed a neuro-oncology fellowship at M. D. Anderson Cancer Center.  Dr. Loghin is involved in patient clinical care as well as in the training program for neuro-oncology fellows and neurology residents. She currently serves as the Department of Neuro-Oncology Residency Program Director, dedicating a lot of effort and energy in developing a competitive and high quality teaching program.

Research Interests

Dr. Loghin's research interests are focused on neurological complications related to cancer treatment, particularly neurological and cognitive deficits induced by radiation therapy. She is collaborating closely with the Neuropschylogy Section in developing new therapeutic strategies  for cancer related cognitive dysfunction.

Clinical Interests

As a neuro-oncologist for patients with primary brain tumors, Dr. Loghin’s primary area of clinical interest  is neurological complications of cancer and cancer-therapy.

Office Address

The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: 431
Houston, TX 77030
Room Number: FC7.3004
Phone: 713-745-4098
Fax: 713-794-4999
Email: mloghin@mdanderson.org

Education & Training

Degree-Granting Education

1983 "Gr.T. Popa" University of Medicine and Pharmacy, Iasi, Romania, MD, Medicine

Postgraduate Training

12/2003-11/2005 Clinical Fellowship, Neuro-Oncology, UT M.D. Anderson Cancer Center, Houston, TX, Dr. Vinay Puduvalli
12/2000-11/2003 Clinical Residency, Neurology, UT Health Science Center, Houston, TX, Dr. Maya Schiess
12/1999-11/2000 Clinical Residency, Internal Medicine, UT Health Science Center, Houston, TX, Dr. Mark Farnie

Board Certifications

2005 The American Board of Psychiatry & Neurology
1992 The Romanian Board of Neurology

Selected Publications

Peer-Reviewed Original Research Articles
1. Loghin M, Prados M, Wen P, Junck L, Lieberman F, Fine H, Fink K, Mehta M, Kuhn J, Lamborn K, Chang S, Cloughesy T, DeAngelis L, Robins HI, Aldape K, Yung, WKA. Phase I study of Temozolomide and Irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: A North American Brain Tumor Consortium study. Clin Cancer Res 13(23):7133-7138, 12/2007. PMID: 18056194.
2. Radu A, Alecu CS, Raclariu A, Nanu L, Loghin M, Stanciu E, Necula A, Ionescu-Tirgoviste C, Patrugan V. CompAc information system for traditional Chinese medicine. Stud Health Technol Inform 81:401-3, 2001. PMID: 11317777.
3. Raclariu A, Alecu S, Loghin M, Serbu L. A consultation system integrating Chinese medical practice in herbaltherapy, acupuncture and acupressure. Stud Health Technol Inform 43(Pt A):285-9., 1997. PMID: 10179555.
4. Loghin M, Prodan R, Stefanache F. The role of evoked potentials in the diagnosis of posterior fossa tumors. Acta Neurologica Moldavica, 1994.
5. Pendefunda G, Prodan R, Loghin M. Cerebral hemorrhage in blood disorders. Journal of the Society of Physicians and Nature Scientists, 1989.

Invited Articles
1. Vaillant B, Loghin M. Treatment of spinal cord tumors. Curr Treat Options Neurol 11(4):315-24, 7/2009. e-Pub 6/2009. PMID: 19523357.
2. Penas-Prado M, Loghin M. Spinal cord compression in cancer patients: Review of diagnosis and treatment. Curr Oncol Rep 10(1):78-85, 1/2008. PMID: 18366964.
3. Loghin M, Levin VA. Headache related to brain tumors. Curr Treat Options Neurol 8(1):21-32, 1/2006. PMID: 16343358.
4. Gilbert MR, Loghin M. The Treatment of Malignant Gliomas. Curr Treat Options Neurol 7(4):293-303, 7/2005. PMID: 15967092.
5. Penas-Prado M, Loghin M. Latest advances in the treatment of malignant gliomas. Hospital Pharmacy Europe. Submitted.

Grant & Contract Support

Title: Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients
Funding Source: NIH/NCI
Role: Principal Investigator-MDACC
Duration: 4/1/2007 - 3/31/2011

Last updated: 8/25/2009